The House Labor, Health and Human Services funding bill is scheduled to be considered by the House Rules Committee today.
National Press Releases
American Cancer Society and ACS CAN Applaud Confirmation of Dr. Monica M. Bertagnolli, MD as Director of the National Institutes of Health (NIH)
The Senate confirmed Dr. Monica M. Bertagnolli, MD, as the new director of the National Institutes of Health (NIH) today.
New data from the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention’s (CDC) National Youth Tobacco Survey (NYTS) found that more than 6.21 million youth reported ever using tobacco products and 2.8 million report current use (past 30 days) of any tobacco product in 2023.
Nearly 1 in 2 Patients with Medical Debt Feel “Trapped”, New Poll from Leading Healthcare Orgs Finds
A new national poll reveals that patients are counting on lawmakers to solve the medical debt crisis. U.S. adults say it is past time for federal and state policymakers to act.
New Survey: 1 in 10 Cancer Patients Has Been Impacted by Nation’s Drug Shortages with Significant Delays to Cancer Care
The nation’s drug shortage crisis continues to affect cancer patients and survivors with 1 in every 10 (10%) reporting impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (59%). The data is part of a new survey by the American Cancer Society Cancer Action Network (ACS CAN).
Regional Eligibility Screening Nearly Doubles Cancer Clinical Trial Opportunities, May Increase Enrollment, New Papers Show
New findings led by researchers at the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) show that regional trial eligibility screening holds the promise of substantially increasing the number of patients who are found eligible to enroll in cancer clinical trials.
CMS Should Prioritize Patients’ Experience as the Administration Negotiates Drug Prices for 2026 Plans
Earlier this week, 22 cancer patient and caregiver advocacy groups, including the American Cancer Society Cancer Action Network (ACS CAN), sent a letter to the Centers for Medicare & Medicaid Services (CMS) offering recommendations on how the agency should consider pharmaceutical therapeutic alternatives to selected oncology drugs for 2026 Medicare plans as they head into the negotiation process laid out in the Inflation Reduction Act (IRA).
CMS Proposes a Medicare Prescription Payment Plan to Allow for More Flexible Payment for Patients Under Part D Prescription Plans
Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted a letter to the Centers for Medicare and Medicaid Services (CMS) commenting on draft guidance related to the maximum monthly cap on patient co-payments under prescription drug plans, referred to as the Medicare Prescription Payment Plan, which will begin in plan year 2025.
Hundreds of Cancer Patients, Survivors Travel to D.C. Urging Congress to Make Cancer a National Priority
As Congress works to determine 2024 priorities before the budget deadline at the end of the month, nearly 700 cancer patients, survivors and their loved ones from all 50 states, Washington, D.C., Guam and Puerto Rico, and nearly every congressional district, will be on Capitol Hill this week to make clear to members of Congress that cancer must be a national priority.